Exact Mass: 353.1488

Exact Mass Matches: 353.1488

Found 92 metabolites which its exact mass value is equals to given mass value 353.1488, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

1-((1-(4-Chlorophenyl)-1H-1,2,3-triazol-4-yl)methyl)-4-phenylpiperazine

1-((1-(4-Chlorophenyl)-1H-1,2,3-triazol-4-yl)methyl)-4-phenylpiperazine

C19H20ClN5 (353.1407)


   

AB 3217-A

(1R,3S,4S,7R,8R,11R,12R,13R)-8-(4-Methoxyphenyl)-2,9,14-trioxa-6-azatricyclo[9.2.1.03,7]tetradecane-4,12,13-triol

C17H23NO7 (353.1474)


   

NCGC00381076-01

NCGC00381076-01

C17H23NO7 (353.1474)


   

(2S-<2alpha,3beta,3<1S*,7aS*>,4alpha>)-<1-(acetoxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl>methyl 3-hydroxy-2,4-dimethyl-5-oxotetrahydrofuran-3-carboxylate|longitubine

(2S-<2alpha,3beta,3<1S*,7aS*>,4alpha>)-<1-(acetoxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl>methyl 3-hydroxy-2,4-dimethyl-5-oxotetrahydrofuran-3-carboxylate|longitubine

C17H23NO7 (353.1474)


   

2-((S)-2-((S)-2-Amino-4-(methylthio)butanamido)-3-phenylPropanamido)acetic acid

2-((S)-2-((S)-2-Amino-4-(methylthio)butanamido)-3-phenylPropanamido)acetic acid

C16H23N3O4S (353.1409)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

C17H23NO7_4-[(2-{[(2-Ethyl-2,3-dihydroxybutanoyl)oxy]methyl}phenyl)amino]-4-oxobutanoic acid

NCGC00381076-01_C17H23NO7_4-[(2-{[(2-Ethyl-2,3-dihydroxybutanoyl)oxy]methyl}phenyl)amino]-4-oxobutanoic acid

C17H23NO7 (353.1474)


   

C17H23NO7_5,8-Epoxy-5H-[1,5]dioxecino[3,2-b]pyrrole-3,6,7-triol, decahydro-11-(4-methoxyphenyl)-, (3S,3aS,5R,6R,7R,8R,11R,11aR)

NCGC00380307-01_C17H23NO7_5,8-Epoxy-5H-[1,5]dioxecino[3,2-b]pyrrole-3,6,7-triol, decahydro-11-(4-methoxyphenyl)-, (3S,3aS,5R,6R,7R,8R,11R,11aR)-

C17H23NO7 (353.1474)


   

4-[2-[(2-ethyl-2,3-dihydroxybutanoyl)oxymethyl]anilino]-4-oxobutanoic acid

4-[2-[(2-ethyl-2,3-dihydroxybutanoyl)oxymethyl]anilino]-4-oxobutanoic acid

C17H23NO7 (353.1474)


   
   
   
   
   
   
   
   

Lys-Val-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-4-methylpentanoic acid

C16H23N3O6 (353.1587)


   

Val-Lys-OH

(S)-7-amino-2-(3-isopropoxy-4-nitrobenzamido)heptanoic acid

C16H23N3O6 (353.1587)


   

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-CHLOROBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-CHLOROBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

C18H24ClNO4 (353.1394)


   

N-BOC-4-(4-CHLORO) BENZYL-4-PIPERIDINE CARBOXYLIC ACID

N-BOC-4-(4-CHLORO) BENZYL-4-PIPERIDINE CARBOXYLIC ACID

C18H24ClNO4 (353.1394)


   

N-benzy-2-(4-(benzyloxy)phenyl)ethanamine

N-benzy-2-(4-(benzyloxy)phenyl)ethanamine

C22H24ClNO (353.1546)


   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-(1h-indol-2-yl)-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-(1h-indol-2-yl)-acetic acid

C20H20FN3O2 (353.1539)


   

Benzyltriphenylphosphonium iodide

Benzyltriphenylphosphonium iodide

C25H22P+ (353.1459)


   

4-CYCLOHEXYL-1-(4-METHYLPHENYLSULFONYL)INDOLE

4-CYCLOHEXYL-1-(4-METHYLPHENYLSULFONYL)INDOLE

C21H23NO2S (353.1449)


   

20-isocyanato-2,5,8,11,14,17-hexaoxabicyclo[16.4.0]docosa-1(18),19,21-triene

20-isocyanato-2,5,8,11,14,17-hexaoxabicyclo[16.4.0]docosa-1(18),19,21-triene

C17H23NO7 (353.1474)


   

3-(Morpholinosulfonyl)phenylboronic acid pinacol ester

3-(Morpholinosulfonyl)phenylboronic acid pinacol ester

C16H24BNO5S (353.1468)


   

6-(Triethoxysilyl)-1-hexanesulfonyl azide

6-(Triethoxysilyl)-1-hexanesulfonyl azide

C12H27N3O5SSi (353.1441)


   

NS-11394

NS-11394

C23H19N3O (353.1528)


NS11394 is an orally active and unique subtype-selective GABAA positive allosteric receptor (PAM), with a Ki of ~0.5 nM. NS11394 shows a selectivity profile in the order of GABAA-5 > α3 > α2 > α1-containing receptors. NS11394 has anxiolytic and anti-inflammatory properties[1][2][3].

   

Arbutamine hydrochloride

Arbutamine hydrochloride

C18H24ClNO4 (353.1394)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

1-((1-(4-Chlorophenyl)-1H-1,2,3-triazol-4-yl)methyl)-4-phenylpiperazine

1-((1-(4-Chlorophenyl)-1H-1,2,3-triazol-4-yl)methyl)-4-phenylpiperazine

C19H20ClN5 (353.1407)


   

2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-hydroxyanilino)-5-pyrimidinecarboxylic acid ethyl ester

2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-hydroxyanilino)-5-pyrimidinecarboxylic acid ethyl ester

C18H19N5O3 (353.1488)


   

2-(1,2-Dihydroimidazo[1,2-a]benzimidazol-4-yl)-1-(4-phenylphenyl)ethanone

2-(1,2-Dihydroimidazo[1,2-a]benzimidazol-4-yl)-1-(4-phenylphenyl)ethanone

C23H19N3O (353.1528)


   

Glycyl-L-phenylalanyl-L-methionine

Glycyl-L-phenylalanyl-L-methionine

C16H23N3O4S (353.1409)


   
   

Serine-3-aminoadenosine

Serine-3-aminoadenosine

C13H19N7O5 (353.1448)


   

3-hydroxy-6-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-5-methoxy-2-(3-methylbut-2-en-1-yl)phenolate

3-hydroxy-6-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-5-methoxy-2-(3-methylbut-2-en-1-yl)phenolate

C21H21O5- (353.1389)


   

2-(4-Hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)-4-oxo-2,3-dihydrochromen-7-olate

2-(4-Hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)-4-oxo-2,3-dihydrochromen-7-olate

C21H21O5- (353.1389)


   

Antibiotic AB3217A

Antibiotic AB3217A

C17H23NO7 (353.1474)


   

4-(phenylmethyl)-3-[2-(4-propoxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione

4-(phenylmethyl)-3-[2-(4-propoxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione

C20H23N3OS (353.1562)


   

2-(3,5-dimethyl-4-nitro-1-pyrazolyl)-N-[(2-methyl-4-quinolinyl)methyl]acetamide

2-(3,5-dimethyl-4-nitro-1-pyrazolyl)-N-[(2-methyl-4-quinolinyl)methyl]acetamide

C18H19N5O3 (353.1488)


   
   

2-[[2-[(2-Fluorophenyl)methoxy]-3-methoxyphenyl]methylamino]phenol

2-[[2-[(2-Fluorophenyl)methoxy]-3-methoxyphenyl]methylamino]phenol

C21H20FNO3 (353.1427)


   

N-hydroxy-N-[(E)-(4-hydroxy-2,6-dimethoxyphenyl)methylideneamino]heptanediamide

N-hydroxy-N-[(E)-(4-hydroxy-2,6-dimethoxyphenyl)methylideneamino]heptanediamide

C16H23N3O6 (353.1587)


   

N-Pyridin-2-yl-3-(o-tolylaminooxalyl-hydrazono)-butyramide

N-Pyridin-2-yl-3-(o-tolylaminooxalyl-hydrazono)-butyramide

C18H19N5O3 (353.1488)


   

7-(4-Chlorophenyl)-5-(4-ethylphenyl)-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine

7-(4-Chlorophenyl)-5-(4-ethylphenyl)-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine

C19H20ClN5 (353.1407)


   

(E)-2-cyano-3-[2-(2,6-dimethylmorpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enamide

(E)-2-cyano-3-[2-(2,6-dimethylmorpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enamide

C18H19N5O3 (353.1488)


   

3-hydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-5-methoxy-6-(3-methylbut-2-en-1-yl)phenolate

3-hydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-5-methoxy-6-(3-methylbut-2-en-1-yl)phenolate

C21H21O5- (353.1389)


   

4-[(5-Methyl-2,4-diphenyl-2H-pyrazol-3-ylimino)-methyl]-phenol

4-[(5-Methyl-2,4-diphenyl-2H-pyrazol-3-ylimino)-methyl]-phenol

C23H19N3O (353.1528)


   
   
   
   
   
   

1-(4-chlorophenyl)-3-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-4-ium

1-(4-chlorophenyl)-3-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-4-ium

C21H22ClN2O+ (353.1421)


   

2-(4-chlorophenyl)-1-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-4-ium

2-(4-chlorophenyl)-1-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-4-ium

C21H22ClN2O+ (353.1421)


   

4-[2-[[1-(Phenylmethyl)-2-benzimidazolyl]thio]ethyl]morpholine

4-[2-[[1-(Phenylmethyl)-2-benzimidazolyl]thio]ethyl]morpholine

C20H23N3OS (353.1562)


   
   
   
   
   
   
   
   
   
   
   

cuevaene A(1-)

cuevaene A(1-)

C21H21O5- (353.1389)


   

3-[[2-(Benzoylamino)phenyl]thio]-5,5-dimethyl-1-cyclohexanone

3-[[2-(Benzoylamino)phenyl]thio]-5,5-dimethyl-1-cyclohexanone

C21H23NO2S (353.1449)


   
   

xanthohumol(1-)

xanthohumol(1-)

C21H21O5 (353.1389)


A phenolate anion that is the conjugate base of xanthohumol, obtained by deprotonation of the 1-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

xanthogalenol(1-)

xanthogalenol(1-)

C21H21O5 (353.1389)


A phenolate anion that is the conjugate base of xanthogalenol, obtained by deprotonation of the 1-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   
   
   

ESI-08

ESI-08

C20H23N3OS (353.1562)


ESI-08 is a potent and selective EPAC antagonist, which can completely inhibit both EPAC1 and EPAC2 (IC50 of 8.4 μM) activity. ESI-08 selectively blocks cAMP-induced EPAC activation, but does not inhibit cAMP-mediated PKA activation[1].

   

ML337

ML337

C21H20FNO3 (353.1427)


ML337 is a selective and brain-penetrant negative allosteric modulator of mGlu3, with an IC50 of 593 nM. ML337 possesses a favorable dystrophia myotonica protein kinase (DMPK) and ancillary pharmacology profile[1]. ML337 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

[7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

[7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C17H23NO7 (353.1474)


   

4-ethylidene-7,12-dihydroxy-7-methyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,6,8-trione

4-ethylidene-7,12-dihydroxy-7-methyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,6,8-trione

C17H23NO7 (353.1474)


   

[(7r,7ar)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

[(7r,7ar)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C17H23NO7 (353.1474)


   

(1r,3s,4s,7r,8r,11r,12s,13r)-8-(4-methoxyphenyl)-2,9,14-trioxa-6-azatricyclo[9.2.1.0³,⁷]tetradecane-4,12,13-triol

(1r,3s,4s,7r,8r,11r,12s,13r)-8-(4-methoxyphenyl)-2,9,14-trioxa-6-azatricyclo[9.2.1.0³,⁷]tetradecane-4,12,13-triol

C17H23NO7 (353.1474)